Real-time enrollment status for this relapsed or refractory b cell acute lymphoblastic leukemia clinical trial
Current Status
Recruiting
Checked: October 17, 2026 at 2:46 AM UTC
| NCT Number | NCT06173518 |
| Recruiting Status | Recruiting |
| Condition | Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia |
| Phase | PHASE1 |
| Target Enrollment | 30 participants |
| Active Locations | 9 sites in the US |
| Sponsor | Autolus Limited |
| Last Updated on CT.gov | October 9, 2026 (1 week ago) |
As of October 17, 2026: Clinical trial NCT06173518 is currently recruiting participants. This phase1 study for relapsed or refractory b cell acute lymphoblastic leukemia is actively seeking new participants at 9 locations across the United States. The study is sponsored by Autolus Limited. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06173518 is actively recruiting participants as of October 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 9 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06173518 was last updated 1 week ago (October 9, 2026). HelloStudys verifies this status automatically.